PARP1 and diabetes mellitus: PARP1 deficiency in mice and PARP inhibitors protect against stroke, I/R injury, sepsis, diabetes, and pancreatitis, suggesting that PARP1 is a potential target in inflammatory disease (Giansanti et al., 2010; Luo and Kraus, 2012).